As a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, we, at Cellectar Biosciences, leverage our proprietary phospholipid ether (PLE) platform to specifically target treatments to cancer cells.
100 Campus Drive, Suite 207
Florham Park, NJ 07932
Tel: 608-441-8120
Fax: 608-441-8121
investors@cellectar.com